These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 12218209)

  • 1. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence re: Mikami Y, Hata S, Kiyokawa T, Manabe T. Expression of CD10 in malignant mullerian mixed tumors and adenosarcomas: an immunohistochemical study. Mod pathol 2002;15:923-30.
    Zamecnik M
    Mod Pathol; 2003 Jun; 16(6):618-9; author reply 619. PubMed ID: 12808069
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mullerian adenosarcoma of the female genital tract.
    McCluggage WG
    Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
    Buza N; Tavassoli FA
    Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.
    Abeler VM; Nenodovic M
    Int J Gynecol Pathol; 2011 May; 30(3):236-43. PubMed ID: 21464730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
    Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
    Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
    Goto M; Nomura Y; Une Y; Goldschmidt MH
    Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
    McCluggage WG; Sumathi VP; Maxwell P
    Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant müllerian mixed tumor (carcinosarcoma) of the fallopian tube: an immunohistochemical study of neoplastic cells.
    Kuroda N; Moriki T; Oguri H; Maeda N; Toi M; Miyazaki E; Hiroi M; Fukaya T; Enzan H
    APMIS; 2005 Sep; 113(9):643-6. PubMed ID: 16218942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
    Shen DH; Khoo US; Xue WC; Ngan HY; Wang JL; Liu VW; Chan YK; Cheung AN
    Cancer; 2001 Mar; 91(5):1052-60. PubMed ID: 11251959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
    Jeffers MD; Richmond JA; Macaulay EM
    Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
    Clement PB; Zubovits JT; Young RH; Scully RE
    Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.